The multiple sclerosis severity score

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Multiple Sclerosis Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Response to therapy in a cohort of patients with late-onset multiple sclerosis

  2025cites this paper
• Lower arterial cerebral blood flow is associated with worse neuroinflammation and immunomodulation composite proteomic scores.

  2024cites this paper
• Cerebrospinal Fluid Chloride Is Associated with Disease Activity of Relapsing–Remitting Multiple Sclerosis: A Retrospective Cohort Study

  2023cites this paper
• Discontinuation of disease-modifying therapy in MS patients over 60 years old and its impact on relapse rate and disease progression.

  2023cites this paper
• Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis

  2023influential citation
• Effect of smoking on disease activity in multiple sclerosis patients treated with dimethyl fumarate or fingolimod.

  2023cites this paper
• Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study

  2023cites this paper
• Altered amide proton transfer weighted and diffusion signals in patients with multiple sclerosis: correlation with neurofilament light chain and disease duration

  2023cites this paper
• Ultra-processed foods consumption is associated with multiple sclerosis severity

  2023cites this paper
• Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review

  2023cites this paper
• Investigating the Effect of Cigarette Smoking on Serum Uric Acid Levels in Multiple Sclerosis Patients: A Cross Sectional Study

  2023cites this paper
• Mood Symptoms and Chronic Fatigue Syndrome Due to Relapsing-Remitting Multiple Sclerosis Are Associated with Immune Activation and Aberrations in the Erythron

  2022cites this paper
• Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: A retrospective cross-sectional study

  2022cites this paper
• The Effects of Disease-Modifying Therapies on Oxidative Stress in Patients With Relapsing-Remitting Multiple Sclerosis

  2022cites this paper
• Evidence for novel cell defense mechanisms sustained by dimethyl fumarate in multiple sclerosis patients: the HuR/SOD2 cascade.

  2022cites this paper
• Baseline neurofilament levels in cerebrospinal fluid do not correlate with long-term prognosis in multiple sclerosis.

  2022cites this paper
• Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany

  2022cites this paper
• K index utility as diagnostic and prognostic biomarker in the assessment of patients with suspected Multiple Sclerosis.

  2022cites this paper
• Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis

  2022cites this paper
• A quarter-century report on neuromyelitis optica spectrum disorder in Thailand: A single-center tertiary care cohort.

  2022cites this paper
• Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical outcomes in multiple sclerosis: a retrospective cross-sectional study

  2022cites this paper
• Two-dimensional measurements with cut-off values are useful for assessing brain volume, physical disability, and processing speed in multiple sclerosis.

  2022cites this paper
• Consensus on early detection of disease progression in patients with multiple sclerosis

  2022cites this paper
• Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate

  2022cites this paper
• The nine hole peg test as an outcome measure in progressive MS trials.

  2022cites this paper
• Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression.

  2022cites this paper
• Metabolic syndrome parameters and multiple sclerosis disease outcomes: A Portuguese cross-sectional study.

  2022cites this paper
• Multimodal magnetic resonance imaging quantification of gray matter alterations in relapsing‐remitting multiple sclerosis and neuromyelitis optica spectrum disorder

  2022cites this paper
• Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes

  2022cites this paper
• Pleiotrophin serum level is increased in Relapsing-Remitting Multiple Sclerosis and correlates with sex, BMI and treatment.

  2021cites this paper
• Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis

  2021cites this paper
• Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis

  2021cites this paper
• Multiple sclerosis limited to spinal cord lesions

  2021cites this paper
• Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018

  2021cites this paper
• Serum neurofilament light is a sensitive biomarker that reflects grey matter volume in Japanese patients with multiple sclerosis.

  2021cites this paper
• Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosis.

  2021cites this paper
• Serum Anti-oligodendrocyte Autoantibodies in Patients With Multiple Sclerosis Detected by a Tissue-Based Immunofluorescence Assay

  2021cites this paper
• Corneal Parameters in Patients with Multiple Sclerosis: A Pilot Study

  2021cites this paper
• The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: a cohort survey.

  2021cites this paper
• Predicting disability worsening in relapsing and progressive multiple sclerosis

  2021cites this paper
• Subcortical lesions in various phenotypes of multiple sclerosis and their prognostic significance

  2021cites this paper
• Maternal education has significant influence on progression in multiple sclerosis.

  2021cites this paper
• Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI.

  2021cites this paper
• Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease.

  2021cites this paper
• Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients

  2021cites this paper
• Assessing the consistency and validity of self-reported year of diagnosis among participants in a longitudinal study of people with multiple sclerosis.

  2021cites this paper
• Association study of rs7799039, rs1137101 and rs8192678 gene variants with disease susceptibility/severity and corresponding LEP, LEPR and PGC1A gene expression in multiple sclerosis.

  2021cites this paper
• HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

  2021cites this paper
• Multiple sclerosis progression and galanin receptor GALR2: is there evidence for a link?

  2021cites this paper
• Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?

  2021cites this paper
• Correlation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosis.

  2021cites this paper
• Is Fertility Affected in Women of Childbearing Age with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?

  2020influential citation
• Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse.

  2020cites this paper
• Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets

  2020cites this paper
• Pediatric Multiple Sclerosis Severity Score in a large US cohort

  2020cites this paper
• Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis.

  2020cites this paper
• Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients

  2020cites this paper
• Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.

  2020cites this paper
• Regarding the publication The Multiple Sclerosis Severity Score: Fluctuations and prognostic ability in a longitudinal cohort of patients with MS authored by RH Gross et al

  2020cites this paper
• Regarding the letter from Roxburgh, et al.

  2020cites this paper
• Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants

  2020cites this paper
• The association of genetic variants IL2RA rs2104286, IFI30 rs11554159 and IKZF3 rs12946510 with multiple sclerosis onset and severity in patients from Serbia.

  2020cites this paper
• Clinical and MRI characteristics of multiple sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada

  2020cites this paper
• The effect of galanin gene polymorphism rs948854 on the severity of multiple sclerosis: A significant association with the age of onset.

  2020cites this paper
• A common genetic variant rs2821557 in KCNA3 is linked to the severity of multiple sclerosis

  2020cites this paper
• Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment

  2020cites this paper
• CHIT1 at Diagnosis Reflects Long‐Term Multiple Sclerosis Disease Activity

  2020cites this paper
• Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype

  2020cites this paper
• Multiple Sclerosis Severity Score: Concept and applications

  2020cites this paper
• Can CSF biomarkers predict future MS disease activity and severity?

  2020cites this paper
• Unraveling a new player in multiple sclerosis pathogenesis: The RNA-binding protein HuR.

  2020cites this paper
• New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

  2020cites this paper
• A roadmap to precision medicine for multiple sclerosis

  2020cites this paper
• Genetic model of MS severity predicts future accumulation of disability

  2020influential citation
• Late onset multiple sclerosis is associated with more severe ventricle expansion.

  2020cites this paper
• On the Reliability of Examining Dual-Tasking Abilities Using a Novel E-Health Device—A Proof of Concept Study in Multiple Sclerosis

  2020cites this paper
• Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis.

  2020cites this paper
• Could the performance of oral glucose tolerance test contribute to the brain health-focused care in multiple sclerosis?

  2020cites this paper
• Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis.

  2020cites this paper
• TNFRSF13C/BAFFR P21R and H159Y polymorphisms in multiple sclerosis.

  2020cites this paper
• Accurate classification of secondary progression in multiple sclerosis using a decision tree

  2020cites this paper
• Wearable inertial sensors provide reliable biomarkers of disease severity in multiple sclerosis: a systematic review and meta-analysis.

  2020cites this paper
• Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study

  2020cites this paper
• Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity

  2020cites this paper
• Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms

  2020cites this paper
• Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis.

  2020cites this paper
• Polymorphisms in proinflammatory cytokines genes and susceptibility to Multiple Sclerosis.

  2020cites this paper
• HLA-DQA1*04:01 is related to a higher multiple sclerosis lesion load on T2/Flair MRI sequences

  2020cites this paper
• Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies

  2019cites this paper
• HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis

  2019cites this paper
• Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis

  2019cites this paper
• Value of gait analysis for measuring disease severity using inertial sensors in patients with multiple sclerosis: protocol for a systematic review and meta-analysis

  2019cites this paper
• Long-term disability progression of pediatric-onset multiple sclerosis

  2019cites this paper
• Fatigue in multiple sclerosis is associated with multimodal interoceptive abnormalities

  2019cites this paper
• Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population

  2019cites this paper
• Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function

  2019cites this paper
• Response to oxidative stress of peripheral blood mononuclear cells from multiple sclerosis patients and healthy controls

  2019cites this paper
• Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity.

  2019cites this paper
• Cranial Nerve Enhancement in Multiple Sclerosis Is Associated With Younger Age at Onset and More Severe Disease

  2019cites this paper
• Expression of LEP, LEPR and PGC1A genes is altered in peripheral blood mononuclear cells of patients with relapsing-remitting multiple sclerosis.

  2019cites this paper